Plasmodium falciparum molecular surveillance to inform the Mozambican National Malaria Control Programme strategy: protocol
Authors:
- Clemente da SilvaCSClemente da Silva
- Gloria MatambissoGMGloria Matambisso
- Simone BoeneSBSimone Boene
- Eduard Rovira-VallbonaEREduard Rovira-Vallbona
- Arnau PujolAPArnau Pujol
- Kiba ComicheKCKiba Comiche
- Antoni SánchezASAntoni Sánchez
- Bryan GreenhouseBGBryan Greenhouse
- Arlindo ChidimatembueACArlindo Chidimatembue
- Andrés Aranda-DíazAAAndrés Aranda-Díaz
- Paulo ArnaldoPAPaulo Arnaldo
- Cristina ArianiCACristina Ariani
Open Access
Abstract
Introduction: Malaria molecular surveillance has the potential to generate information on biological threats that compromise the effectiveness of antimalarial interventions. This study aims to streamline surveillance activities to inform the new strategic plan of the Mozambican National Malaria Control Programme (2023–2030) for malaria control and elimination. Methods and analyses: This prospective genomic surveillance study aims to generate Plasmodium falciparum genetic data to monitor diagnostic failures due to pfhrp2/3 deletions and molecular markers of antimalarial drug resistance, to characterise transmission sources and to inform the implementation of new antimalarial approaches to be introduced in Mozambique (chemoprevention and child malaria vaccination). The study, to be conducted between 2024 and 2026, will use three sampling schemes: a multicluster probabilistic health facility survey in the 10 provinces of the country to detect pfhrp2/3 deletions and markers of antimalarial drug resistance; dense sampling of all clinical cases in representative districts in the south targeted for elimination to characterise malaria importation and identify sources of transmission; and testing of pregnant women for malaria at their first antenatal care visit to assess malaria burden and molecular trends. Using a multiplex amplicon-based sequencing approach, the study will target microhaplotypes informative of genomic diversity and relatedness, as well as key drug resistance-associated genes, pfhrp2/3 deletion and malaria vaccine targets. Key genomic information will be visualised in a dashboard integrated into the District Health Information System V.2-based Malaria Information Storage System for programmatic use. Ethics and dissemination: The protocol was reviewed and approved by the national ethics committee of Mozambique (Comité Nacional de Bioética para Saúde, Ref: 680/CNBS/23). Project results will be presented to all stakeholders using study-specific brochures and published in open-access journals. Trial registration number: NCT06529237 .Keywords
All Related Versions
Funding Information
- Bill and Melinda Gates Foundation (INV-067310)
This publication has 49 references indexed in Scilit:
- Monitoring antifolate resistance in intermittent preventive therapy for malariaTrends in Parasitology, 2013
- Strategies for Detection of Plasmodium species GametocytesPLOS ONE, 2013
- Genetic Surveillance Detects Both Clonal and Epidemic Transmission of Malaria following Enhanced Intervention in SenegalPLOS ONE, 2013
- A model of parity-dependent immunity to placental malariaNature Communications, 2013
- Population genetic correlates of declining transmission in a human pathogenMolecular Ecology, 2012
- A Large Proportion of P. falciparum Isolates in the Amazon Region of Peru Lack pfhrp2 and pfhrp3: Implications for Malaria Rapid Diagnostic TestsPLOS ONE, 2010
- A general SNP-based molecular barcode for Plasmodium falciparum identification and trackingMalaria Journal, 2008
- Detection of Four Plasmodium Species in Blood from Humans by 18S rRNA Gene Subunit-Based and Species-Specific Real-Time PCR AssaysJournal of Clinical Microbiology, 2004
- Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCRMolecular and Biochemical Parasitology, 2001
- Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine ResistanceMolecular Cell, 2000